Epigenetic checkpoint blockade: new booster for immunotherapy

Signal Transduct Target Ther. 2021 Jul 22;6(1):281. doi: 10.1038/s41392-021-00707-z.

Authors

Ziqiao Wang¹, Bingjing Wang¹, Xuetao Cao^{2

3}

Affiliations

¹ Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
² Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. caoxt@immunol.org.
³ Laboratory of Immunity and Inflammation, College of Life Sciences, Nankai University, Tianjin, China. caoxt@immunol.org.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Epigenesis, Genetic
Immunologic Factors
Immunotherapy* / adverse effects
Programmed Cell Death 1 Receptor*

Substances

Immunologic Factors
Programmed Cell Death 1 Receptor